Form 8-K - Current report:
SEC Accession No. 0001193125-25-000984
Filing Date
2025-01-03
Accepted
2025-01-03 06:06:02
Documents
17
Period of Report
2025-01-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d894156d8k.htm   iXBRL 8-K 35836
2 EX-10.1 d894156dex101.htm EX-10.1 48349
3 EX-10.2 d894156dex102.htm EX-10.2 49692
4 EX-10.3 d894156dex103.htm EX-10.3 47102
  Complete submission text file 0001193125-25-000984.txt   390310

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250102.xsd EX-101.SCH 4470
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250102_def.xml EX-101.DEF 13888
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250102_lab.xml EX-101.LAB 23244
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250102_pre.xml EX-101.PRE 14857
20 EXTRACTED XBRL INSTANCE DOCUMENT d894156d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25503663
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)